NCT06566729View on ClinicalTrials.gov

MRD in High-risk EBC

Active, not recruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

April 30, 2028

Conditions
Breast Cancer
Interventions
OTHER

Peripheral blood sample collection

In this study, peripheral blood samples would be collected before adjuvant chemotherapy, after adjuvant chemotherapy and every 3 months thereafter until 2 years after surgery.

Trial Locations (1)

200025

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER